Table 1 Patient characteristics and surgical factors
Group SEV (n = 40) | Group TIVA (n = 40) | p-value | |
|---|---|---|---|
Age (years) | 49.5 (9.5) | 48.7 (10.6) | 0.704 |
Height (cm) | 161.6 (4.6) | 161.2 (5.5) | 0.663 |
Weight (kg) | 58.2 (7.2) | 57.0 (6.3) | 0.630 |
ASA grade | 0.446 | ||
I | 31 (77.5) | 28 (70) | |
II | 9 (22.5) | 12 (30) | |
Tumor size (mm) | 2.1 (0.9) | 2.2 (1.0) | 0.626 |
Histological Grade | 0.644 | ||
I | 7 (17.5) | 8 (20.0) | |
II | 17 (42.5) | 20 (50.0) | |
III | 16 (40.0) | 12 (30.0) | |
Carcinoma cell embolus | 11 (27.5) | 17 (42.5) | 0.160 |
Nerve invasion | 5 (12.5) | 5 (12.5) | 1.000 |
Positive receptors | |||
Estrogen | 26 (65.0) | 32 (80.0) | 0.133 |
Progesterone | 22 (55.0) | 27 (67.5) | 0.251 |
HER2 expression | 15 (37.5) | 12 (30.8) | 0.528 |
TNM Staging | 0.995 | ||
Tis | 1 (2.5) | 1 (2.5) | |
Stage I | 12 (30.0) | 13 (32.5) | |
Stage II | 19 (47.5) | 18 (45.0) | |
Stage III | 8 (20.0) | 8 (20.0) | |
Duration of anesthesia (min) | 79.0 (30.5) | 79.4 (26.3) | 0.592 |
Surgical approach | 0.820 | ||
MRM | 23 (57.5) | 24 (60.0) | |
BCS | 17 (42.5) | 16 (40.0) | |